Antiplatelet therapy and anticoagulants

The Lancet

Volumn 382, Issue 9886, 2013, Pages 24-25

  Schlitt, Axel ^a   Rubboli, Andrea ^b   Airaksinen, Kari Eino Juhani ^c   Lip, Gregory Y H ^d  

^a Paracelsus Harz Clinic Bad Suderode   (Germany)

^b MAGGIORE HOSPITAL   (Italy)

^c TURKU UNIVERSITY HOSPITAL   (Finland)

^d UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; DRUG DERIVATIVE; TICLOPIDINE;

ADVERSE OUTCOME; ANTICOAGULANT THERAPY; CORONARY STENT; HUMAN; INCIDENCE; LETTER; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; FEMALE; MALE; NOTE;

ANTICOAGULANTS; ASPIRIN; FEMALE; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; TICLOPIDINE;

EID: 84879872404     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)61521-4     Document Type: Letter

References (3)

1. WJ Dewilde, T Oirbans, FW Verheugt et al. Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial Lancet 381 2013 1107 1115
2. GY Lip, K Huber, F Andreotti et al. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary - a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) Eur Heart J 31 2010 1311 1318
3. JM Ruiz-Nodar, F Marín, GY Lip Antithrombotic management and type of stent in atrial fibrillation patients undergoing percutaneous coronary intervention Rev Esp Cardiol 6 2013 12 16